Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Correction

Balaxi Pharmaceuticals Results Correction

Balaxi Pharmaceuticals clarified reporting discrepancies in its March 2026 financial results. The company filed revised XBRL results to correct inadvertent errors in expense and income figures.

Source

NSE filing, NSE: BALAXI. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Balaxi Pharmaceuticals Ltd: key numbers

Share price
₹20.33
Market cap
₹112.2 Cr
Revenue (annual)
₹270.2 Cr
Net profit (annual)
₹1.42 Cr
P/E (TTM)
46.3×Sector 46.1×
Promoter holding
65.99%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Balaxi Pharmaceuticals Ltd

All →

Other results correction announcements

All →